Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery

被引:66
作者
Asai, Tomohiro [1 ]
Tsuzuku, Takuma [1 ]
Takahashi, Shoya [1 ]
Okamoto, Ayaka [1 ]
Dewa, Takehisa [2 ]
Nango, Mamoru [2 ]
Hyodo, Kenji [3 ]
Ishihara, Hiroshi [3 ]
Kikuchi, Hiroshi [3 ]
Oku, Naoto [1 ]
机构
[1] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Suruga Ku, Shizuoka 4228526, Japan
[2] Nagoya Inst Technol, Dept Life & Mat Engn, Showa Ku, Nagoya, Aichi 4668555, Japan
[3] Eisai & Co Ltd, Eisai Prod Creat Syst, Pharmaceut Sci & Technol Core Funct Unit, Global Formulat Res, Tsukuba, Ibaraki 3002635, Japan
基金
日本学术振兴会;
关键词
Lipid nanoparticles; Cell-penetrating peptides; Small interfering RNA; SMALL INTERFERING RNA; SYSTEMIC DELIVERY; POLYCATION LIPOSOMES;
D O I
10.1016/j.bbrc.2014.01.107
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Lipid nanoparticles (LNP) modified with cell-penetrating peptides (CPP) were prepared for the delivery of small interfering RNA (siRNA) into cells. Lipid derivatives of CPP derived from protamine were newly synthesized and used to prepare CPP-decorated LNP (CPP-LNP). Encapsulation of siRNA into CPP-LNP improved the stability of the siRNA in serum. Fluorescence-labeled siRNA formulated in CPP-LNP was efficiently internalized into B16F10 murine melanoma cells in a time-dependent manner, although that in LNP without CPP was hardly internalized into these cells. In cells transfected with siRNA in CPP-LNP, most of the siRNA was distributed in the cytoplasm of these cells and did not localize in the lysosomes. Analysis of the endocytotic pathway indicated that CPP-LNP were mainly internalized via macropinocytosis and heparan sulfate-mediated endocytosis. CPP-LNP encapsulating siRNA effectively induced RNA interference-mediated silencing of reporter genes in B16F10 cells expressing luciferase and in HT1080 human fibrosarcoma cells expressing enhanced green fluorescent protein. These data suggest that modification of LNP with the protamine-derived CPP was effective to facilitate internalization of siRNA in the cytoplasm and thereby to enhance gene silencing. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:599 / 604
页数:6
相关论文
共 16 条
[1]
Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression [J].
Aleku, Manuela ;
Schulz, Petra ;
Keil, Oliver ;
Santel, Ansgar ;
Schaeper, Ute ;
Dieckhoff, Britta ;
Janke, Oliver ;
Endruschat, Jens ;
Durieux, Birgit ;
Roeder, Nadine ;
Loeffler, Kathrin ;
Lange, Christian ;
Fechtner, Melanie ;
Moepert, Kristin ;
Fisch, Gerald ;
Dames, Sibylle ;
Arnold, Wolfgang ;
Jochims, Karin ;
Giese, Klaus ;
Wiedenmann, Bertram ;
Scholz, Arne ;
Kaufmann, Joerg .
CANCER RESEARCH, 2008, 68 (23) :9788-9798
[2]
Dicetyl Phosphate-Tetraethylenepentamine-Based Liposomes for Systemic siRNA Delivery [J].
Asai, Tomohiro ;
Matsushita, Saori ;
Kenjo, Eriya ;
Tsuzuku, Takuma ;
Yonenaga, Norihito ;
Koide, Hiroyuki ;
Hatanaka, Kentaro ;
Dewa, Takehisa ;
Nango, Mamoru ;
Maeda, Noriyuki ;
Kikuchi, Hiroshi ;
Oku, Naoto .
BIOCONJUGATE CHEMISTRY, 2011, 22 (03) :429-435
[3]
Intracellular delivery of nanopartides via the HIV-1 tat pepticle [J].
Berry, C. C. .
NANOMEDICINE, 2008, 3 (03) :357-365
[4]
The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine [J].
Choi, Young-Suk ;
Lee, Jue Yeon ;
Suh, Jin Sook ;
Kwon, Young-Min ;
Lee, Seung-Jin ;
Chung, Jun-Key ;
Lee, Dong-Soo ;
Yang, Victor C. ;
Chung, Chong-Pyoung ;
Park, Yoon-Jeong .
BIOMATERIALS, 2010, 31 (06) :1429-1443
[5]
Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid [J].
Hatakeyama, Hiroto ;
Akita, Hidetaka ;
Ito, Erika ;
Hayashi, Yasuhiro ;
Oishi, Motoi ;
Nagasaki, Yukio ;
Danev, Radostin ;
Nagayama, Kuniaki ;
Kaji, Noritada ;
Kikuchi, Hiroshi ;
Baba, Yoshinobu ;
Harashima, Hideyoshi .
BIOMATERIALS, 2011, 32 (18) :4306-4316
[6]
Development of Double-Stranded siRNA Labeling Method Using Positron Emitter and Its In Vivo Trafficking Analyzed by Positron Emission Tomography [J].
Hatanaka, Kentaro ;
Asai, Tomohiro ;
Koide, Hiroyuki ;
Kenjo, Eriya ;
Tsuzuku, Takuma ;
Harada, Norihiro ;
Tsukada, Hideo ;
Oku, Naoto .
BIOCONJUGATE CHEMISTRY, 2010, 21 (04) :756-763
[7]
Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles [J].
Kanazawa, Takanori ;
Sugawara, Ken ;
Tanaka, Ko ;
Horiuchi, Shogo ;
Takashima, Yuuki ;
Okada, Hiroaki .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 81 (03) :470-477
[8]
Systemic Delivery of Small Interfering RNA by Use of Targeted Polycation Liposomes for Cancer Therapy [J].
Kenjo, Eriya ;
Asai, Tomohiro ;
Yonenaga, Norihito ;
Ando, Hidenori ;
Ishii, Takayuki ;
Hatanaka, Kentaro ;
Shimizu, Kosuke ;
Urita, Yugo ;
Dewa, Takehisa ;
Nango, Mamoru ;
Tsukada, Hideo ;
Oku, Naoto .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2013, 36 (02) :287-291
[9]
Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system [J].
Kogure, Kentaro ;
Akita, Hidetaka ;
Yamada, Yuma ;
Harashima, Hideyoshi .
ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (4-5) :559-571
[10]
Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells [J].
Li, Shyh-Dar ;
Huang, Leaf .
MOLECULAR PHARMACEUTICS, 2006, 3 (05) :579-588